Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2131 AL 2145

[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status

Machulda MM, Hagen CE, Wiste HJ, Mielke MM, Knopman DS, Roberts RO, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC.

Clin Neuropsychol. 2017 Jan;31(1):99-117. doi: 10.1080/13854046.2016.1241303. Epub 2016 Oct 11.

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease

Brody M, Liu E, Di J, Lu M, Margolin RA, Werth JL, Booth K, Shadman A, Brashear HR, Novak G.

J Alzheimers Dis. 2016 Oct 18;54(4):1509-1519. doi: 10.3233/JAD-160369.

Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease

Kokkonen N, Herukka SK, Huilaja L, Kokki M, Koivisto AM, Hartikainen P, Remes AM, Tasanen K.

J Invest Dermatol. 2017 Jan;137(1):71-76. doi: 10.1016/j.jid.2016.09.010. Epub 2016 Sep 17.

Alzheimer disease: Biomarkers of AD risk - the end of the road for plasma amyloid-β?

Wood H.

Nat Rev Neurol. 2016 Nov;12(11):613. doi: 10.1038/nrneurol.2016.160. Epub 2016 Oct 14.

Structural neuroimaging in preclinical dementia: From microstructural deficits and grey matter atrophy to macroscale connectomic changes

Mak E, Gabel S, Mirette H, Su L, Williams GB, Waldman A, Wells K, Ritchie K, Ritchie C, O'Brien J.

Ageing Res Rev. 2017 May;35:250-264. doi: 10.1016/j.arr.2016.10.001. Epub 2016 Oct 21.

Towards Personalized Intervention for Alzheimer's Disease

Peng X, Xing P, Li X, Qian Y, Song F, Bai Z, Han G, Lei H.

Genomics Proteomics Bioinformatics. 2016 Oct;14(5):289-297. doi: 10.1016/j.gpb.2016.01.006. Epub 2016 Sep 28.

Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies

Golde TE.

J Neurochem. 2016 Oct;139 Suppl 2(Suppl 2):224-236. doi: 10.1111/jnc.13583. Epub 2016 May 4.

Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease

Kulic L, Unschuld PG.

Curr Opin Neurol. 2016 Dec;29(6):749-755. doi: 10.1097/WCO.0000000000000399.

Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease

Jovalekic A, Bullich S, Catafau A, de Santi S.

Neurodegener Dis Manag. 2016 Dec;6(6):491-497. doi: 10.2217/nmt-2016-0026. Epub 2016 Nov 4.

Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis

Kim BY, Lee SH, Graham PL, Angelucci F, Lucia A, Pareja-Galeano H, Leyhe T, Turana Y, Lee IR, Yoon JH, Shin JI.

Mol Neurobiol. 2017 Nov;54(9):7297-7311. doi: 10.1007/s12035-016-0192-9. Epub 2016 Nov 4.

The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming

Fanni D, Gerosa C, Rais M, Ravarino A, Van Eyken P, Fanos V, Faa G.

Neurosci Lett. 2018 Mar 16;669:75-82. doi: 10.1016/j.neulet.2016.10.063. Epub 2016 Nov 3.

Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease

Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt KL.

Expert Opin Pharmacother. 2016 Dec;17(18):2417-2429. doi: 10.1080/14656566.2016.1258060. Epub 2016 Nov 22.

Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review

Bemelmans SA, Tromp K, Bunnik EM, Milne RJ, Badger S, Brayne C, Schermer MH, Richard E.

Alzheimers Res Ther. 2016 Nov 10;8(1):46. doi: 10.1186/s13195-016-0212-z.

Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid

Roberts BR, Doecke JD, Rembach A, Yévenes LF, Fowler CJ, McLean CA, Lind M, Volitakis I, Masters CL, Bush AI, Hare DJ; AIBL research group.

Acta Neuropathol Commun. 2016 Nov 14;4(1):119. doi: 10.1186/s40478-016-0390-8.

In Vivo Comparison of Tau Radioligands (18)F-THK-5351 and (18)F-THK-5317

Betthauser TJ, Lao PJ, Murali D, Barnhart TE, Furumoto S, Okamura N, Stone CK, Johnson SC, Christian BT.

J Nucl Med. 2017 Jun;58(6):996-1002. doi: 10.2967/jnumed.116.182980. Epub 2016 Nov 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias